ro.co tv serenas on ro in the ro.co TV spot and in real life Introducing our newest partner: Serena Williams is a Ro member and lost 31 lbs in 8 months on GLP-1s.* Safety info: GLP-1 medications may have serious side effects, including possible thyroid tumors
Tirzepatide is contraindicated in pregnancy and should be discontinued at least 2 months before planned conception (its half-life is approximately 5 days, but a safety margin is standard)
Mild discomfort is expected
Novo Nordisk is committing 432 million to expand its tabletting manufacturing facility in Monksland, Athlone, Ireland
Are your eyes glazed over yet

: JAMA Psychiatry study highlights (semaglutide in schizophrenia spectrum disorders): Studied adults with schizophrenia spectrum disorders treated with clozapine or olanzapine, two antipsychotics strongly linked to weight gain and metabolic syndrome Participants were randomized to receive semaglutide (GLP-1 receptor agonist) vs placebo, in addition to usual psychiatric care Significant weight loss was observed in the semaglutide group compared with placebo Improved glycemic control including reductions in HbA1c and fasting glucose, even in early metabolic dysregulation Beneficial effects seen early, suggesting potential for prevention of diabetes rather than late treatment Semaglutide was generally well tolerated, with no worsening of psychotic symptoms Addresses a major unmet need, people with serious mental illness die earlier largely due to cardiometabolic disease Supports the role of GLP-1 receptor agonists as an adjunct treatment to mitigate antipsychotic-induced metabolic harm Bottom line: A promising strategy to reduce weight, diabetes risk, and long-term cardiovascular mortality in patients on high-risk antipsychotics
